Scientists map how cinnamon’s bioactives interact with cancer signaling +++++

https://www.news-medical.net/news/20251215/Scientists-map-how-cinnamone28099s-bioactives-interact-with-cancer-signaling.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=bowel_cancer_newsletter_18_december_2025 Laboratory studies suggest cinnamon’s bioactive compounds can alter key cancer-related signaling pathways, but researchers caution that human trials are essential before any preventive or therapeutic claims can be made. New insights explain the Treg paradox in colorectal cancer https://www.news-medical.net/news/20251215/New-insights-explain-the-Treg-paradox-in-colorectal-cancer.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=bowel_cancer_newsletter_18_december_2025 Blood test identifies colon cancer patients who benefit from anti-inflammatory medicationBlood test identifies colon cancer patients who benefit from anti-inflammatory medication https://www.news-medical.net/news/20251215/Blood-test-identifies-colon-cancer-patients-who-benefit-from-anti-inflammatory-medication.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=bowel_cancer_newsletter_18_december_2025 A blood test could help doctors decide which patients with colon cancer should receive anti-inflammatory medication along with chemotherapy after surgery, according to new study in JAMA Oncology. Frog-derived bacteria offer dual-action anticancer effects and high safetyFrog-derived bacteria offer dual-action anticancer effects and high safety https://www.news-medical.net/news/20251216/Frog-derived-bacteria-offer-dual-action-anticancer-effects-and-high-safety.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=bowel_cancer_newsletter_18_december_2025 A research team of Prof. Eijiro Miyako at the Japan Advanced Institute of Science and Technology (JAIST) has discovered that the bacterium Ewingella americana, isolated from the intestines of Japanese tree frogs (Dryophytes japonicus), possesses remarkably potent anticancer activity. This groundbreaking research has been published in the international journal Gut Microbes. Early scans reveal prostate radiotherapy toxicity riskEarly scans reveal prostate radiotherapy toxicity risk https://www.news-medical.net/news/20251211/Early-scans-reveal-prostate-radiotherapy-toxicity-risk.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=bowel_cancer_newsletter_18_december_2025 Daily scans taken during prostate cancer radiotherapy could be repurposed to guide changes to treatment, reducing the risk of side effects, a study suggests.